Abstract
Bone cancer brings patients great sufferings and puts an end to normal activities in life. In clinic, the most common treatment for bone cancer is the combination of surgery and chemo-/radiotherapy. However, surgery is difficult to eliminate tumor cells completely and results in large bone defect. Chemo-/radiotherapy is associated with chemo-/radioresistance and evident short-/long-term toxic effects. Therefore, the development of a novel bio-scaffold for local treatment of residual tumor cells and regeneration of bone defect induced by surgery has become a very urgent need. Some progress has been made in the development of scaffolds with the ability of both tumor therapy and bone regeneration. These scaffolds function as local agents and selectively kill the tumor cells via photothermal/magnetothermal therapy or local chemotherapy. Compared with traditional treatment, they have no side effects. In addition, scaffolds possess satisfactory biocompatibility, stimulating the migration, adhesion, proliferation, and differentiation of bone marrow stroma cells. Furthermore, they can promote gene expression of BMSCs and formation of new bone. Therefore, to bone tumor-suffering patients, it is a very meaningful progress in the biomedical application. Hopefully, more efforts and progress will be made in the development of scaffolds for the treatment of tumor-induced bone defects, and more research will continue to inform and guide this field.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Driel M, Leeuwen JPTM (2014) Cancer and bone: a complex complex. Arch Biochem Biophys 561:159–166
Mundy GR (2002) Metastasis: metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2:584–593
Buenrostro D, Mulcrone PL, Owens P, Sterling JA (2016) The bone microenvironment: a fertile soil for tumor growth. Curr Osteoporos Rep 14:151–158
Paget S (1889) The distribution of secondary growths in cancer of the breast. Lancet 1:571–573
Guise TA, Yin JJ, Taylor SD et al (1996) Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. J Clin Invest 98:1544–1549
Yin JJ, Selander K, Chirgwin JM et al (1999) TGF-β signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. J Clin Invest 103:197–206
Hiraga T, Williams PJ, Mundy GR, Yoneda T (2001) The bisphosphonate ibandronate promotes apoptosis in MDA-MB-231 human breast cancer cells in bone metastases. Cancer Res 61:4418–4424
Fidler IJ (2003) The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat Rev Cancer 3:453–458
Chou AJ, Geller DS, Gorlick R (2008) Therapy for osteosarcoma: where do we go from here? Paediatr Drugs 10:315–327
Yasko AW (2009) Surgical management of primary osteosarcoma. Cancer Treat Res 152:125–145
Marulanda GA, Henderson ER, Johnson DA, Letson GD, Cheong D (2008) Orthopedic surgery options for the treatment of primary osteosarcoma. Cancer Control 15:13–20
Errani C, Longhi A, Rossi G et al (2011) Palliative therapy for osteosarcoma. Expert Rev Anticancer Ther 11:217–227
Grimer RJ, Taminiau AM, Cannon SR (2002) Surgical outcomes in osteosarcoma. J Bone Joint Surg Br 84-B:395–400
Healy KE, Guldberg RE (2007) Bone tissue engineering. J Musculoskelet Neuronal Interact 7(4):328–330
Bird JE (2014) Advances in the surgical management of bone tumors. Curr Oncol Rep 16:392–397
Chao P-HG, Grayson W, Vunjak-Novakovic G (2007) Engineering cartilage and bone using human mesenchymal stem cells. J Orthop Sci 12:398–404
Smeland S, Bruland ØS, Hjorth L et al (2011) Results of the Scandinavian Sarcoma Group XIV protocol for classical osteosarcoma. Acta Orthop 82:211–216
Janeway KA, Grier HE (2010) Sequelae of osteosarcoma medical therapy: a review of rare acute toxicities and late effects. Lancet Oncol 11:670–678
Chou AJ, Gorlick R (2014) Chemotherapy resistance in osteosarcoma: current challenges and future directions. Expert Rev Anticancer 6:1075–1085
Hattinger CM, Pasello M, Ferrari S et al (2010) Emerging drugs for high-grade osteosarcoma. Expert Opin Emerg Dr 15:615–634
Ozaki T, Flege S, Liljenqvist U et al (2002) Osteosarcoma of the spine. Cancer 94:1069–1077
Meijer TWH, Kaanders JHAM, Span PN, Bussink J (2012) Targeting hypoxia, HIF-1, and tumor glucose metabolism to improve radiotherapy efficacy. Clin Cancer Res 18:5585–5594
Zhuang Q, Zhang Z, Fu H et al (2011) Does radiation-induced fibrosis have an important role in pathophysiology of the osteoradionecrosis of jaw? Med Hypotheses 77:63–65
Da Cunha SS, Sarmento V, Ramalho LMP et al (2007) Effect of laser therapy on bone tissue submitted to radiotherapy: experimental study in rats. Photomed Laser Surg 25:197–204
Rabelo GD, Beletti ME, Dechichi P (2010) Histological analysis of the alterations on cortical bone channels network after radiotherapy: a rabbit study. Microsc Res Tech 73:1015–1018
Mavrogenis AF, Angelini A, Vottis C et al (2016) Modern palliative treatments for metastatic bone disease. Clin J Pain 32:337–350
Böhm P, Huber J (2002) The surgical treatment of bony metastases of the spine and limbs. J Bone Joint Surg (Br) 84-B:521–529
Harrington KD (1997) Orthopedic surgical management of skeletal complications of malignancy. Cancer 80:1614–1627
Habash RW, Bansal R, Krewski D, Alhafid HT (2006) Thermal therapy, part 2: hyperthermia techniques. Crit Rev Bioeng 34:491–542
Wunderlich CA, Woodman WB (1871) On the temperature in diseases: a manual of medical thermometry. The New Sydenham Society, London
Jaque D, Maestro LM, del Rosal B et al (2014) Nanoparticles for photothermal therapies. Nanoscale 6:9494–9530
Habash RW, Bansal R, Krewski D, Alhafid HT (2006) Thermal therapy, part 1: an introduction to thermal therapy. Crit Rev Bioeng 34:459–489
Hildebrandt B, Wust P, Ahlers O, Dieing A et al (2002) The cellular and molecular basis of hyperthermia. Crit Rev Oncol Hemat 43:33–56
Fisher JW, Sarkar S, Buchanan CF et al (2010) Photothermal response of human and murine cancer cells to multiwalled carbon nanotubes after laser irradiation. Cancer Res 70:9855–9864
Takahashi HT, Nariai A, Niidome Y, Yamada S (2006) Photothermal reshaping of gold nanorods prevents further cell death. Nanotechnology 17:4431–4435
Oleson JR, Samulski TV, Leopold KA, Clegg ST et al (1993) Sensitivity of hyperthermia trial outcomes to temperature and time: implication for thermal goals of treatment. Radiat Oncol Biol Phys 25:289–297
Chu KF, Dupuy DE (2014) Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer 14:199–208
Chen Q, Wen J, Li H et al (2016) Recent advances in different modal imaging-guided photothermal therapy. Biomaterials 106:144–166
Young JK, Figueroa ER, Drezek RA (2012) Tunable nanostructures as photothermal theranostic agents. Ann Biomed Eng 40:438–459
Cheng L, Wang C, Feng L et al (2014) Functional nanomaterials for phototherapies of cancer. Chem Rev 114:10869–10939
Wang Z, Huang P, Jacobson O et al (2016) Biomineralization-inspired synthesis of Copper Sulfide–Ferritin Nanocages as cancer theranostics. ACS Nano 10:3453–3460
Yang Y, Liu J, Liang C et al (2016) Nanoscale metal–organic particles with rapid clearance for magnetic resonance imaging-guided photothermal therapy. ACS Nano 10:2774–2781
Smith AM, Mancini MC, Nie S (2009) Bioimaging: second window for in vivo imaging. Nat Nanotechnol 4:710–711
Weissleder R (2001) A clearer vision for in vivo imaging. Nat Biotechnol 19:316–317
Gilchrist RK, Medal R, Shorey WD, Hanselman RC et al (1957) Selective inductive heating of lymph nodes. Ann Surg 146:596–606
Pankhurst QA, Connolly J, Jones SK, Dobson J (2003) Applications of magnetic nanoparticles in biomedicine. J Phys D Appl Phys 36:167–181
Mornet SP, Vasseur SB, Grasset F, Duguet E (2004) Magnetic nanoparticle design for medical diagnosis and therapy. J Mater Chem 14:2161–2175
Hergt R, Dutz S, Röder M (2006) Effects of size distribution on hysteresis losses of magnetic nanoparticles for hyperthermia. J Phys Condens Matter 18:2919–2934
Ma H, Jiang C, Zhai D et al (2016) A bifunctional biomaterial with photothermal effect for tumor therapy and bone regeneration. Adv Funct Mater 26:1197–1208
Zhang Y, Nayak TR, Hong H, Cai W (2012) Graphene: a versatile nanoplatform for biomedical applications. Nanoscale 4:3833–3842
Lee WC, Lim CHYX, Shi H et al (2011) Origin of enhanced stem cell growth and differentiation on graphene and graphene oxide. ACS Nano 5:7334–7341
Yang K, Zhang S, Zhang G et al (2010) Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy. Nano Lett 10:3318–3323
Robinson JT, Tabakman SM, Liang Y et al (2011) Ultrasmall reduced graphene oxide with high near-infrared absorbance for photothermal therapy. J Am Chem Soc 133:6825–6831
Gonçalves G, Vila M, Portolés M-T et al (2013) Nano-graphene oxide: a potential multifunctional platform for cancer therapy. Adv Healthc Mater 2:1072–1090
Ivaska KK, Hentunen TA, Vaaraniemi J et al (2004) Release of intact and fragmented osteocalcin molecules from bone matrix during bone resorption in vitro. J Biol Chem 279:18361–18369
Alford AI, Hankenson KD (2006) Matricellular proteins: extracellular modulators of bone development, remodeling, and regeneration. Bone 38:749–757
Wu C, Xia L, Han P et al (2015) Graphene-oxide-modified β-tricalcium phosphate bioceramics stimulate in vitro and in vivo osteogenesis. Carbon 93:116–129
Hong J, Shah NJ, Drake AC et al (2012) Graphene multilayers as gates for multi-week sequential release of proteins from surfaces. ACS Nano 6:81–88
La W-G, Park S, Yoon H-H et al (2013) Delivery of a therapeutic protein for bone regeneration from a substrate coated with graphene oxide. Small 9:4051–4060
Andronescu E, Ficai M, Voicu G et al (2010) Synthesis and characterization of collagen/hydroxyapatite: magnetite composite material for bone cancer treatment. J Mater Sci Mater Med 21:2237–2242
Kawashita M, Kawamura K, Li Z (2010) PMMA-based bone cements containing magnetite particles for the hyperthermia of cancer. Acta Biomater 6:3187–3192
Tampieri A, D’Alessandro T, Sandri M et al (2012) Intrinsic magnetism and hyperthermia in bioactive Fe-doped hydroxyapatite. Acta Biomater 8:843–851
Gloria A, Russo T, D’Amora U et al (2013) Magnetic poly(ε-caprolactone)/iron-doped hydroxyapatite nanocomposite substrates for advanced bone tissue engineering. J R Soc Interface 10:20120833
Wei G, Ma PX (2008) Nanostructured biomaterials for regeneration. Adv Funct Mater 18:3568–3582
Bañobre-López M, Pineiro-Redondo Y, Sandri M et al (2014) Hyperthermia induced in magnetic scaffolds for bone tissue engineering. IEEE Trans Magn 50:1–7
Zhang Y, Zhai D, Xu M et al (2016) 3D-printed bioceramic scaffolds with a Fe3O4/graphene oxide nanocomposite interface for hyperthermia therapy of bone tumor cells. J Mater Chem B 4:2874–2886
Zhang J, Zhao S, Zhu M et al (2014) 3D-printed magnetic Fe3O4/MBG/PCL composite scaffolds with multifunctionality of bone regeneration, local anticancer drug delivery and hyperthermia. J Maters Chem B 2:7583–7595
Wu C, Fan W, Chang J (2013) Functional mesoporous bioactive glass nanospheres: synthesis, high loading efficiency, controllable delivery of doxorubicin and inhibitory effect on bone cancer cells. J Mater Chem B 1:2710–2718
Tsai HC, Chang WH, Lo CL et al (2010) Graft and diblock copolymer multifunctional micelles for cancer chemotherapy and imaging. Biomaterials 31:2293–2301
Verstappen CCP, Heimans JJ, Hoekman K, Postma TJ (2003) Neurotoxic complications of chemotherapy in patients with cancer. Drugs 63:1549–1563
Meazza C, Scanagatta P (2016) Metastatic osteosarcoma: a challenging multidisciplinary treatment. Expert Rev of Anticancer 16:543–556
Chen KH, Po-Kuei Wu PK, Chen CF, Chen WM (2015) Zoledronic acid-loaded bone cement as a local adjuvant therapy for giant cell tumor of the sacrum after intralesional curettage. Eur Spine J 24:2182–2188
Acknowledgments
Funding for this study was provided by the Recruitment Program of Global Young Talent, China (Dr. Wu), National Key Research and Development Program of China (2016YFB0700803), the National High Technology Research and Development Program of China (863 Program, SS2015AA020302), Natural Science Foundation of China (Grant 81430012, 31370963), Key Research Program of Frontier Sciences, CAS (QYZDB-SSW-SYS027), and Program of Shanghai Outstanding Academic Leaders (15XD1503900).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Ma, H., Chang, J., Wu, C. (2018). 3D Printing of Calcium Phosphate Bio-scaffolds for Bone Therapy and Regeneration. In: Liu, C., He, H. (eds) Developments and Applications of Calcium Phosphate Bone Cements. Springer Series in Biomaterials Science and Engineering, vol 9. Springer, Singapore. https://doi.org/10.1007/978-981-10-5975-9_12
Download citation
DOI: https://doi.org/10.1007/978-981-10-5975-9_12
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-5974-2
Online ISBN: 978-981-10-5975-9
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)